Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: A meta-analysis

Renal Failure

Volumn 34, Issue 8, 2012, Pages 1052-1057

  Cheng, Hui Yuan ^a   You, Hao Yuan ^b   Zhou, Tian Biao ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Gene polymorphism; GSTM1; GSTT1; Meta analysis; Renal cell carcinoma

Indexed keywords

ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHINA BIOLOGICAL MEDICINE; COCHRANE LIBRARY; DATA BASE; EMBASE; GENE; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HUMAN; KIDNEY CARCINOMA; MEDLINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84865243625     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.708380     Document Type: Review

References (41)

1. Akagi EM, Junior PL, Simons SM, Bellini MH, Barreto SA, Chudzinski-Tavassi AM. Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro". Biomed Pharmacother. 2012;66:64-69.
2. Gao H, Dong B, Jia J, et al. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases. J Cancer Res Clin Oncol. 2012;138:753-761.
3. Chu H, Wang M, Yan F, et al. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann Oncol. 2012. doi:10.1093/annonc/mdr607
4. Ahmad ST, Arjumand W, Seth A, et al. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes. Urol Oncol. 2012. doi:10.1016/j.urolonc.2011.12.009
5. Arjumand W, Ahmad ST, Seth A, Saini AK, Vitamin SS. D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol. 2012;33:23-31.
6. Zhang L, Qiu L, Wu H, et al. Expression profiles of seven glutathione S-transferase (GST) genes from Venerupis philippinarum exposed to heavy metals and benzoapyrene. Comp Biochem Physiol C Toxicol Pharmacol. 2012;155:517-527.
7. Datta SK, Kumar V, Pathak R, et al. Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail. 2010;32:1189-1195.
8. Salah GB, Kallabi F, Maatoug S, et al. Polymorphisms of glutathione S-transferases M1, T1, P1 and A1 genes in the Tunisian population: An intra and interethnic comparative approach. Gene. 2012;498:317-322.
9. Langevin SM, Ioannidis JP, Vineis P, Taioli E. Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: Application of the Venice interim guidelines. Pharmacogenet Genomics. 2010;20:586-597.
10. Safarinejad MR, Shafiei N, Safarinejad SH. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: A case-control study in Tehran, Iran. Prostate Cancer Prostatic Dis. 2011;14:105-113.
11. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Urol Oncol. 2011. doi:10.1016/j. urolonc.2011.11.027
12. Ramalhinho AC, Fonseca-Moutinho JA, Breitenfeld L. Glutathione S-transferase M1, T1, and P1 genotypes and breast cancer risk: A study in a Portuguese population. Mol Cell Biochem. 2011;355:265-271.
13. Chen YL, Tseng HS, Kuo WH, Yang SF, Chen DR, Tsai HT. Glutathione S-transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma. BMC Med Genet. 2010;11:46.
14. Qin YH, Zhou TB, Su LN, Lei FY, Zhao YJ, Huang WF. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: A meta-analysis of 13 randomized controlled trials. Blood Coagul Fibrinolysis. 2010;21:713-721.
15. Zhou TB, Qin YH, Su LN, et al. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroidresistant nephrotic syndrome for children: A genetic association study and meta-analysis. Ren Fail. 2011;33:741-748.
16. ZhouTB,LiuYG,Lin N, et al.Relationship between angiotensinconverting enzymeinsertion/deletion gene polymorphismand systemic lupus erythematosus/lupus nephritis: A systematic review andmetaanalysis. J Rheumatol. 2012; 39:686-693.
17. Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12:624-633.
18. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJACE. I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: A metaanalysis. PLoS One. 2011;6:e19599.
19. Zhou TB, Qin YH, Ou C, et al. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children. J Renin Angiotensin Aldosterone Syst. 2012;13:175-183.
20. Zhou TB, Ou C, Qin YH, et al. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011;12:601-610.
21. Zhou TB, Lin N, Liu YG, Qin YH, Shao MB, Peng DD. Association of ACE I/D gene polymorphism with vesicoureteral reflux susceptibility in children: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2012;13:273-281.
22. Wang X, Jie YW. Timing of initiation of renal replacement therapy in acute kidney injury: A systematic review and metaanalysis. Ren Fail. 2012;34(3):396-402.
23. He Q, Zhang W, Chen J. A meta-analysis of icodextrin versus glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients. Ren Fail. 2011;33:943-948.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
25. Egger M, Davey SG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
26. SweeneyC, FarrowDC, SchwartzSM, EatonDL,Checkoway H, Vaughan TL. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: A case-control study. Cancer Epidemiol Biomarkers Prev. 2000;9:449-454.
27. Bruning T, Lammert M, Kempkes M, Thier R, Golka K, Bolt HM. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol. 1997;71: 596-599.
28. Longuemaux S, Delomenie C, Gallou C, et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res. 1999;59:2903-2908.
29. Karami S, Boffetta P, Rothman N, et al. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis. 2008;29: 1567-1571.
30. De Martino M, Klatte T, Schatzl G, et al. Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene. J Urol. 2010;183:878-883.
31. Ahmad ST, Arjumand W, Seth A, Saini AK, Sultana S. Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma. DNA Cell Biol. 2012;31:636-643.
32. Sun QP, Li LY, Chen Z, et al. Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: A pilot study. J Mol Diagn. 2010;12:718-724.
33. Jung S, Jeong D, Kim J, et al. The role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancer. Oncol Rep. 2010;23:1675-1682.
34. Moribe T, Iizuka N, Miura T, et al. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Int J Oncol. 2008;33:949-958.
35. Gong M, Dong W, An R. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: A meta-analysis involving 50 studies. DNA Cell Biol. 2012. doi:10.1089/dna.2011.1567
36. Zhang ZJ, Hao K, Shi R, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: A HuGE review and meta-analysis. Am J Epidemiol. 2011;173:847-857.
37. Chen B, Cao L, Zhou Y, et al. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: A meta-analysis of epidemiologic studies. Dig Dis Sci. 2010;55:1831-1838.
38. Gao LB, Pan XM, Li LJ, et al. Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: An evidencebased meta-analysis. PLoS One. 2011;6:e20157.
39. Xu D, Yan S, Yin J, Zhang P. Null genotype of GSTT1 contributes to colorectal cancer risk in Asian populations: Evidence from a meta-analysis. Asian Pac J Cancer Prev. 2011;12: 2279-2284.
40. Zhong S, Yang JH, Liu K, Jiao BH, Chang Z. Null genotype of glutathione S-transferase Tl contributes to colorectal cancer risk in the Asian population: A meta-analysis. J Gastroenterol Hepatol. 2012;27:231-237.
41. Liao C, Cao Y, Wu L, Huang J, Gao F. An updating metaanalysis of the glutathione S-transferase T1 polymorphisms and colorectal cancer risk: A HuGE review. Int J Colorectal Dis. 2010;25:25-37.